Evidence map›Paper›PMID 39722760›Full record

ArticleWorld journal of virology2024

Acceptance of COVID-19 vaccine and its related determinants in Nigeria: An online survey.

Eyiuche D Ezigbo, Seyi S Enitan, Esther N Adejumo, Abiodun E Durosinmi, Richard Y Akele, Michael O Dada, Grace E Itodo, Abah M Idoko, Okeoghene M Edafetanure-Ibeh, Edwin N Okafor and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of virology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Eyiuche D EzigboHaemostasis and Thrombosis Unit, Department of Medical Laboratory Sciences, University of Nigeria, Enugu Campus, Enugu, EN 400241, Nigeria.
Seyi S EnitanDepartment of Medical Laboratory Science, School of Public and Allied Health, Babcock University, Ilishan-Remo, OG 121109, Nigeria. enitans@babcock.edu.ng.
Esther N AdejumoDepartment of Medical Laboratory Science, School of Public and Allied Health, Babcock University, Ilishan-Remo, OG 121109, Nigeria.
Abiodun E DurosinmiDepartment of Medical Laboratory Science, State Hospital, Ijebu-Ode, OG 120221, Nigeria.
Richard Y AkeleDepartment of Biomedical Science, School of Applied Science, University of Brighton, Brighton, ES BN2 4AT, United Kingdom.
Michael O DadaDepartment of Medical Laboratory Science, School of Public and Allied Health, Babcock University, Ilishan-Remo, OG 121109, Nigeria.
Grace E ItodoDepartment of Microbiology, Federal Teaching Hospital Lokoja, Lokoja, KO 260006, Nigeria.
Abah M IdokoDepartment of Hematology and Blood Group Serology, Federal College of Veterinary and Medical Laboratory Technology, Vom, PL 930101, Nigeria.
Okeoghene M Edafetanure-IbehDepartment of Environmental and Occupational Health, Texas A and M University School of Public Health, Garland, TX 75049, United States.
Edwin N OkaforDivision of Chemical Pathology, Department of Medical Laboratory Sciences, University of Nigeria, Enugu Campus, Enugu, EN 400102, Nigeria.
Adedeji A AbdulsalamSchool of Molecular Bioscience Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, SCO G12 8QQ, United Kingdom.
Oyekan I OyedoyinDepartment of Medical Laboratory Science, State Hospital Ijebu-Ode, Ijebu-Ode, OG 360101, Nigeria.
Polit U YelpojiDepartment of Medical Laboratory Science, Faculty of Health Sciences and Technology, University of Jos, Jos, PL 930103, Nigeria.
Ogunwola O OpeyemiDepartment of Medical Laboratory Science, Bola Tinubu Health and Diagnostic Center, Lagos, LA 100102, Nigeria.
Ogbuji S NmesomachiDepartment of Pathology, 68 Nigerian Army Reference Hospital, Yaba, LA 1211001, Nigeria.
Adesola O OyekaleDepartment of Medical Laboratory Science, Ladoke Akintola University of Technology, Ogbomoso, OS 2111105, Nigeria.
Chisom B OnyejiDepartment of Medical Laboratory Science, School of Public and Allied Health, Babcock University, Ilishan-Remo, OG 121109, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVaccine hesitancy is a major challenge in the fight against the coronavirus disease 2019 (COVID-19) pandemic. Identifying the sociodemographic factors associated with vaccine acceptance among Nigerians is crucial for improving vaccine uptake.

aimTo assess the acceptance rate of COVID-19 vaccine and its related determinants among Nigerians.

methodsAn online cross-sectional survey (observational study) was conducted between February 2021 and May 2021, using a questionnaire hosted on SurveyMonkey. The invitation to take part in the poll was sent out to participants through social networking platforms. A logistic regression was used to determine which sociodemographic factors were associated with vaccine acceptance constructs.

resultsA total of 1800 persons responded to the survey, a larger proportion of whom were males (53.9%) and within the age group of 21-30 years (29.4%) and earned an average income of less than $500 per month (43.3%). Only 0.56% of participants had a high perceived risk of COVID-19 infection, while only 1.11% had a perceived risk of dying from COVID-19. The perception rate of the COVID-19 vaccine among participants was 51.1%, while the acceptance rate was 63.9%. There was no significant association between the COVID-19 vaccine acceptance rate and related determinants assessed, particularly age (

conclusionDespite the positive perception observed and substantial vaccine acceptance rate among the study participants, more public health interventions are still needed to enhance vaccine acceptability in Nigeria.

Indexed as

AcceptanceCOVID-19DeterminantsHesitancyNigeriansOnline surveyVaccine

Identifiers

PMID39722760
PMCPMC11551692

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.